Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. Its flagship research and development programs are focused on advancing formulations to significantly improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders. The company was founded by Richard Greenberg on November 10, 1952 and is headquartered in Glendale, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nexien BioPharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nexien BioPharma Inc market cap is $849,300.00.
What is the 52-week high for Nexien BioPharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nexien BioPharma Inc 52 week high is $0.0495 as of October 10, 2025.
What is the 52-week low for Nexien BioPharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nexien BioPharma Inc 52 week low is $0.0014 as of October 10, 2025.
What is Nexien BioPharma Inc stock price today?
Nexien BioPharma Inc stock price today is $0.012.
What was Nexien BioPharma Inc stock price yesterday?
Nexien BioPharma Inc stock price yesterday was $0.012.
What is the PE ratio of Nexien BioPharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nexien BioPharma Inc’s P/E ratio is -4.29.
What is the Price-to-Book ratio of Nexien BioPharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nexien BioPharma Inc P/B ratio is -1.8838.
What is the 50-day moving average of Nexien BioPharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nexien BioPharma Inc 50-day moving average is $0.0084.
